Latest Nasdaq News

Page 8 of 41
Neuren Pharmaceuticals saw a record Q2 with DAYBUE net sales hitting US$125 million, driven by strong uptake of the new STIX formulation. The company upgraded its 2026 royalty guidance following Acadia Pharmaceuticals’ sales boost and awaits key regulatory milestones in Europe and Japan.
Victor Sage
Victor Sage
5 Aug 2026
JPMorgan Asset Management has revised the estimated cash distributions for its four Equity Premium Income Complex ETFs for August 2026, with payments scheduled mid-month.
Claire Turing
Claire Turing
4 Aug 2026
IperionX plans to relocate its parent company to Texas and list directly on Nasdaq, aligning its corporate structure with its US operations. The appointment of manufacturing veteran Michael J. Loparco aims to bolster the company’s industrial scale-up.
Maxwell Dee
Maxwell Dee
3 Aug 2026
Elevra Lithium has issued the first tranche of C$65 million convertible notes to support the North American Lithium Brownfield Expansion, following shareholder approval in July 2026.
Maxwell Dee
Maxwell Dee
3 Aug 2026
American Rare Earths has ramped up feasibility drilling and pilot plant development at its Halleck Creek Rare Earths Project, while bolstering leadership and progressing preparations for a NASDAQ listing.
Maxwell Dee
Maxwell Dee
31 July 2026
Chilwa Minerals has more than doubled its Mpyupyu heavy mineral sands resource to 109.6 million tonnes, defined a maiden niobium-rare earths exploration target at Nakombe, and progressed its planned Nasdaq dual listing with the SEC.
Maxwell Dee
Maxwell Dee
31 July 2026
Jindalee Lithium is pushing ahead with its McDermitt Lithium Project in the US, securing shareholder approval for a NASDAQ listing via US Elemental and raising $10.9 million to fund drilling and testwork. The project aims to deliver both lithium and magnesium, aligning with US critical minerals priorities.
Maxwell Dee
Maxwell Dee
31 July 2026
Alterity Therapeutics has cleared a major regulatory hurdle with the FDA endorsing a single pivotal Phase 3 trial for its ATH434 drug in Multiple System Atrophy, setting the stage for trial initiation by the end of 2026.
Ada Torres
Ada Torres
30 July 2026
IperionX reports steady ramp-up of titanium powder output at Virginia facility, successful commissioning of major powder metallurgy equipment, and progress in customer product development. The Titan DFS confirms strong project economics, while the Atlas acquisition broadens critical mineral resources and infrastructure.
Maxwell Dee
Maxwell Dee
30 July 2026
Ioneer Ltd continues to build momentum on its Rhyolite Ridge lithium-boron project, signing strategic MOUs with Korean partners and navigating a legal appeal while preparing for construction.
Maxwell Dee
Maxwell Dee
30 July 2026
Metallium has validated its Flash Joule Heating technology through extensive testing and multi-reactor operation, advancing towards commercial e-waste processing at its Texas campus in H1 2027.
Maxwell Dee
Maxwell Dee
30 July 2026
Tungsten Mining has locked in a robust economic case for its Watershed project with a pre-tax NPV of A$1.31 billion and IRR near 200%, while launching its largest-ever drilling campaign at Mt Mulgine to underpin long-term growth.
Maxwell Dee
Maxwell Dee
30 July 2026

Browse the archive

Full archive